Factors associated with decisions about clinical BRCA1/2 testing.

  title={Factors associated with decisions about clinical BRCA1/2 testing.},
  author={Katrina A Armstrong and Kathleen A Calzone and Jill Stopfer and G. Fitzgerald and James Coyne and Barbara K. Weber},
  journal={Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology},
  volume={9 11},
Testing for mutations in BRCA1 and BRCA2 can provide important information about breast and ovarian cancer risk to a small but identifiable subgroup of women. Women who test positive for a BRCA1/2 mutation can pursue more aggressive cancer surveillance and prevention regimens. Among families with known mutations, women who test negative may avoid unnecessary interventions. Currently, little is known about the factors associated with the use of clinical BRCA1/2 testing. The objective of this… CONTINUE READING

From This Paper

Topics from this paper.
52 Citations
0 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 52 extracted citations

Similar Papers

Loading similar papers…